NCT00188162CompletedPhase 1
Can Minimum Dose CT Post Lung Biopsy Predict Patient Outcome?
University Health Network, Toronto1 site in 1 country100 target enrollmentStarted: January 1, 2004Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Detection of Pneumothorax
Study Overview
Brief Summary
The aim is to evaluate whether Minimum Dose CT (MnDCT) is useful in the management of patients post Lung Biopsy
Detailed Description
Patients post Lung Biopsy have a chest X-ray (CXR) and a MnDCT post lung biopsy. Both studies are compared for the detection of a pneumothorax
Study Design
- Study Type
- Interventional
- Allocation
- Non Randomized
- Intervention Model
- Single Group
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 16 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •All Patients having a lung biopsy
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Detection of Pneumothorax
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Phase 1
Computed Tomography (CT) in Head and Neck PatientsLung TumorsNCT00188656University Health Network, Toronto100
Completed
Phase 1
Study of Low Dose CT in Sarcoma PatientsSoft Tissue SarcomaNCT00188422University Health Network, Toronto70
Active, not recruiting
Not Applicable
LDCT Screening in Non-smokers in TaiwanLung CancerNCT02611570Academia Sinica, Taiwan12,000
Completed
Not Applicable
Low-Dose Chest CT (LDCT) COVID-19 StudyCovid19NCT05031845Kaiser Permanente121
Completed
Not Applicable
Low Dose Chest Computed Tomography (CT) ScreeningHodgkin's LymphomaNCT01180010University Health Network, Toronto31